Navigation Links
O2h Continues to Support Senexis to Support Patent Filing Senexis Limited
Date:6/14/2010

/span>. O2h adheres to the highest standards of performance with a particular emphasis on rapid interactive communications and delivery speed. Services provided by O2h include FTE-based synthetic chemistry, medicinal chemistry, computational chemistry, full services lab-units and ADME. Further information on O2h can be found at http://www.o2h.com.

About Senexis Limited

Senexis is a drug discovery and development company, dedicated to the discovery of effective treatments and diagnostics for major ageing-related diseases, such as Alzheimer's dementia. It is now widely believed that the misfolding and aggregation of amyloid-like proteins underlies the pathologies of Alzheimer's disease and Senexis has discovered potent and selective compounds that protect cells and tissues from the toxic forms of amyloid. Senexis is now actively seeking development partners and further information on Senexis can be found at http://www.senexis.com.

    Contact information:
    Ekta Ahuja PhD
    info@o2h.com
    OXYGEN HEALTHCARE LTD
    23 Cambridge Science Park
    CB4 0EY

    Contact:
    SENEXIS LIMITED
    Babraham Research Campus
    Babraham, Cambridge, UK
    CB22 3AT


'/>"/>
SOURCE Oxygen Healthcare Ltd (O2h)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Regado Biosciences, Inc. Continues to Expand Its Patent Portfolio By Announcing Issuance of a New Patent for Its Product Candidates, the REG1 and REG2 Anticoagulation Systems
2. NEVO(TM) Sirolimus-Eluting Coronary Stent Continues to Demonstrate Excellent Safety and Efficacy Outcomes in New Twelve-Month Data
3. Dehaier Medical Systems Continues Product Line Expansion. Signs Exclusive Distribution Agreement with HEYER Medical for Respiratory Products in China
4. US Oncology Continues to Set the Standard as a VAWD(CM) Accredited Wholesale Distributor
5. Igen Networks Corp continues to build a world class advisory board
6. Indiana Continues to Make Its Mark as a Leading Life Sciences Center
7. Astrogenetix Continues MRSA Vaccine Development Onboard Endeavor
8. The MedZilla Report for January 2010 - Health Care Closes 2009 Strong, But Pharma Continues Shedding Jobs
9. TechCFO Continues Research Triangle Park Expansion; Garrison Named New Partner
10. Arena Pharmaceuticals Announces Merck Discontinues Development of Investigational Niacin Receptor Agonist Program for Atherosclerosis
11. Health Robotics Continues its Global Expansion With December 09 ASHPs Launch of Joint Venture in Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... LIBERTYVILLE, Ill. (PRWEB) , ... ... ... a leading provider of regulatory compliance, quality systems, analytical testing, education and ... consulting firm with expertise in medical device products/processes development, design control, validation, ...
(Date:9/2/2015)... , Sep. 02, 2015 ... addition of Jain PharmaBiotech,s new report "Gene Therapy ... The markets for gene therapy are difficult ... therapy product and it is marketed in ... estimated for the years 2014-2024. The estimates are based ...
(Date:9/2/2015)... , Sept. 2, 2015 Australian prostate cancer ... prestigious Australian science prize recognising ,outstanding, science that uses ... to globally launch a novel prostate cancer diagnostic test ... high level consortium taking out the peer-reviewed Australian Museum ... Research. This prize is awarded for ...
(Date:9/2/2015)... September 2, 2015 Biovista ... Wettbewerbs BeHEARD von 2015 bekanntgeben zu können. Hierbei ... Genomics Institute. Biovista unterstützt mit seiner ... die Behandlung anderer Krankheiten als denen, für die ... und sein Team bei der Wylder Nation ...
Breaking Biology Technology:NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 2NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 3NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 4NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 5NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 6NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 7Global Gene Therapy Market Study 2015-2024 - Technologies, Markets and Companies Analysis 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3Biovista sponsert die Forschung von Wylder Nation Foundation zum Thema Mangel an saurer Sphingomyelinase 2
... Sweden and CAMBRIDGE, England, April 23 ... drug discovery (FBDD) today,announced a new commercial ... and Beactica AB, based in Uppsala, Sweden, ... lead discovery and optimization,platform., The IOTA-Beactica ...
... Combination with Taxol and Paraplatin Will Become the, Clinical Gold ... ... Decision Resources, WALTHAM, Mass., April 23 ... on pharmaceutical and,healthcare issues, finds that surveyed oncologists say that a ...
... CIA patients treated with PBI-1402 did not require blood ... ... - ProMetic Life Sciences Inc.,(TSX: PLI) ("ProMetic") announces that oral PBI-1402 ... for red blood cell ("RBC") transfusion., Only 2 patients out ...
Cached Biology Technology:New Fragment-based Drug Discovery Platform Announced Between IOTA Pharmaceuticals Ltd, Cambridge (UK), and Beactica AB, Uppsala (Sweden) 2Avastin Used in Combination with Drugs from Bristol-Myers Squibb Has Advantages in Survival Rates Over the Current Sales-Leading Therapy for Advanced Ovarian Cancer 2Avastin Used in Combination with Drugs from Bristol-Myers Squibb Has Advantages in Survival Rates Over the Current Sales-Leading Therapy for Advanced Ovarian Cancer 3Oral PBI-1402 Demonstrates Significant Activity in Chemotherapy-Induced Anemia Phase II Clinical Trial 2Oral PBI-1402 Demonstrates Significant Activity in Chemotherapy-Induced Anemia Phase II Clinical Trial 3
(Date:8/19/2015)... 19, 2015  VOXX International Corporation (Nasdaq: ... into a Definitive Agreement to purchase the assets, ... market leader EyeLock through an acquiring entity.  Upon ... controlling interest in the acquiring entity. The closing ... due diligence.  Expanding on its existing supply chain ...
(Date:8/12/2015)... Minn. , Aug. 12, 2015   MedNet ... supports the entire spectrum of clinical research, is proud ... , the company,s comprehensive SaaS-based eClinical technology platform, has ... during the first two quarters of 2015.   Q2 ... second largest quarters measured by contract value sold in ...
(Date:8/11/2015)... 2015 Today, ZUK announced its Android smartphone ... as expected revenues in 2015 that relate to sales of FPC1155 ... of approximately 2,200 MSEK for 2015. Jörgen Lantto, CEO ... prominent smartphone manufacturer in China ... FPC1 155 for Z1 , ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5MedNet Solutions Experiences Explosive Corporate Growth 2FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
... in Central Illinois are being exposed to polychlorinated biphenyls (PCBs) ... 1970s and ,80s. Their analysis appears in ... Illinois Department of Natural Resources collected 23 river otters between ... by cars or accidentally caught in traps, for example). The ...
... and other amphibians around the world releases a toxic ... investigators report Oct. 18 in the journal Science ... a long-standing puzzle why the amphibian immune system ... said Louise Rollins-Smith, Ph.D., associate professor of Pathology, Microbiology ...
... Oct. 10, 2013   DigitalPersona, Inc. , a ... announced the acquisition of Identity Stream, a leading ... identification of customers and employees in financial institutions.  ... Temenos, the banking software company, as T24 Biometrics.  ...
Cached Biology News:Illinois river otters exposed to chemicals banned decades ago 2Illinois river otters exposed to chemicals banned decades ago 3Frog-killing fungus paralyzes amphibian immune response 2DigitalPersona Expands Secure Banking Solutions Portfolio with Software Acquisition 2DigitalPersona Expands Secure Banking Solutions Portfolio with Software Acquisition 3
Identify and characterize Phosphoinositide (PI(4,5)P2) binding...
... These skirted micro test tubes are used ... polypropylene, these tubes have uniform walls for ... with separate O-ring screw caps. The O-rings ... have an operating range from -55 to ...
... Sac-Cel (Second Antibody Coated CELlulose) was developed ... of Dartford, Kent, one of the earliest ... IDS acquired the product range in 1987. ... clinical biochemists developing their own "in house" ...
Determine relative degree of protein binding to phosphoinositides...
Biology Products: